[Form 4] CASSAVA SCIENCES INC Insider Trading Activity

Rhea-AI Filing Summary

Robert Christopher Cook, listed as Chief Operating & Legal Officer and a director of Cassava Sciences, Inc. (SAVA), reported an insider purchase on 09/30/2025. The Form 4 shows an acquisition of 13,725 shares of common stock at a price of $2.91 per share, and the filing reports 13,725 shares beneficially owned following the transaction. The report was signed under power of attorney on 10/02/2025.

Positive

• Insider purchase of 13,725 common shares at $2.91 per share
• Reporting person is a senior executive (Chief Operating & Legal Officer) and director, indicating management participation

Negative

• None.

Insights

Corporate Governance Analyst

Insider purchase of 13,725 shares at $2.91 signals a direct personal acquisition.

The Form 4 documents a straightforward non-derivative purchase by a senior officer and director on 09/30/2025, increasing reported beneficial ownership to 13,725 shares.

This type of filing is notable because it is a direct purchase by management, which investors often view as alignment of interests; the document contains no additional compensation, options, or derivative activity.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Cook Robert Christopher

(Last) (First) (Middle)

6801 N CAPITAL OF TEXAS HWY, BLDG 1

SUITE 300

(Street)

AUSTIN TX 78731

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CASSAVA SCIENCES INC [ SAVA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Operating & Legal Office

3. Date of Earliest Transaction (Month/Day/Year)
09/30/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/30/2025		P		13,725	A	$2.91	13,725	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Eric J. Schoen by Power of Attorney	10/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider activity did Cassava Sciences (SAVA) report?

The Form 4 reports that Robert Christopher Cook purchased 13,725 shares of Cassava Sciences common stock on 09/30/2025 at $2.91 per share.

What is Robert C. Cook's role at SAVA?

The filing lists him as a Director and the company's Chief Operating & Legal Officer.

How many Cassava shares does the reporting person beneficially own after the transaction?

The Form 4 shows 13,725 shares beneficially owned following the reported transaction.

When was the Form 4 signed and filed?

The signature block shows the form executed by power of attorney on 10/02/2025; the transaction date is 09/30/2025.

Did the Form 4 report any derivative transactions or options?

No; Table II for derivative securities contains no reported transactions or holdings.